Assembly Biosciences (ASMB) EBITDA Margin (QoQ) (2017 - 2026)
Powered by 
Analysis
Assembly Biosciences (ASMB) EBITDA Margin (QoQ) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Assembly Biosciences | 685.61 Mn | 365.25 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9,100.00 |
| Mar 31, 2026 | -18,506.00 |
| Dec 31, 2025 | 14,749.00 |
| Sep 30, 2025 | 1,437.00 |
| Jun 30, 2025 | -970.00 |
| Mar 31, 2025 | 5,121.00 |
| Dec 31, 2024 | 331.00 |
| Sep 30, 2024 | -1,705.00 |
| Jun 30, 2024 | 4,245.00 |
| Mar 31, 2024 | -1,024.00 |
| Dec 31, 2020 | -381,115.00 |
| Sep 30, 2020 | -2,832.00 |
| Jun 30, 2020 | 69,532.00 |
| Mar 31, 2020 | -7,689.00 |
| Dec 31, 2019 | 1,263.00 |
| Sep 30, 2019 | 2,526.00 |
| Jun 30, 2019 | 8,976.00 |
| Mar 31, 2019 | -2,463.00 |
| Dec 31, 2018 | -17,802.00 |
| Sep 30, 2018 | 31,747.00 |